Generex Biotechnology Corporation
GNBTQ
OTC PK
| 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | 04/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 181.04% | -28.50% | 5,278.06% | -96.28% | 54.81% |
| Total Receivables | -69.14% | -7.83% | 11.52% | 16.13% | -40.81% |
| Inventory | -62.44% | -14.01% | -3.19% | -18.52% | 5.79% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.88% | 26.86% | -7.67% | -46.73% | 23.75% |
| Total Current Assets | 39.28% | -13.24% | 62.81% | -40.06% | 11.70% |
|
|
|||||
| Total Current Assets | 39.28% | -13.24% | 62.81% | -40.06% | 11.70% |
| Net Property, Plant & Equipment | -15.63% | 63.95% | -21.56% | -34.34% | -40.88% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | -11.34% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | -11.34% | 0.00% |
| Total Other Intangibles | -2.58% | -2.53% | -2.47% | -10.76% | -1.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.15% | 0.00% | 0.00% | -4.46% | -29.11% |
| Total Assets | 0.91% | -0.82% | 1.11% | -12.55% | -0.40% |
|
|
|||||
| Total Accounts Payable | 4.18% | 17.49% | 39.97% | 11.01% | -10.70% |
| Total Accrued Expenses | 5.93% | 6.02% | 6.11% | 6.20% | -- |
| Short-term Debt | -1.11% | 0.00% | 0.00% | 0.00% | -88.64% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.83% | 1.40% | -6.77% | -8.08% | 12,697.25% |
| Total Finance Division Other Current Liabilities | 88.85% | 28.55% | 133.15% | 0.00% | 0.00% |
| Total Other Current Liabilities | 88.85% | 28.55% | 133.15% | 0.00% | 0.00% |
| Total Current Liabilities | 7.35% | 13.81% | 26.76% | 4.18% | 5.74% |
|
|
|||||
| Total Current Liabilities | 7.35% | 13.81% | 26.76% | 4.18% | 5.74% |
| Long-Term Debt | 10.43% | -0.06% | 0.02% | 0.04% | -- |
| Short-term Debt | -1.11% | 0.00% | 0.00% | 0.00% | -88.64% |
| Capital Leases | -11.41% | -- | -- | -- | -17.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -37.31% | 61.44% | 119.16% | 8.46% | 0.55% |
| Total Liabilities | -10.55% | 29.14% | 46.28% | 4.90% | 5.62% |
|
|
|||||
| Common Stock & APIC | 0.54% | 0.39% | -2.63% | 0.50% | 1.77% |
| Retained Earnings | 1.89% | -5.18% | -2.78% | -2.65% | -1.29% |
| Treasury Stock & Other | 53.62% | -36.94% | -0.28% | 3,084.90% | 226.67% |
| Total Common Equity | 17.28% | -50.18% | -111.34% | -69.45% | 12.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.28% | -50.18% | -111.34% | -69.45% | 12.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -5.68% | -2.45% | -1.90% | -1.49% | -25.54% |
| Total Equity | 20.01% | -72.05% | -306.28% | -807.12% | -72.29% |
|
|
|||||
